المؤلفون: Larocca A., Leleu X., Touzeau C., Blade J., Paner A., Mateos M. -V., Cavo M., Maisel C., Alegre A., Oriol A., Raptis A., Rodriguez-Otero P., Mazumder A., Laubach J., Nadeem O., Sandberg A., Orre M., Torrang A., Bakker N. A., Richardson P. G.

المساهمون: Larocca A., Leleu X., Touzeau C., Blade J., Paner A., Mateos M.-V., Cavo M., Maisel C., Alegre A., Oriol A., Raptis A., Rodriguez-Otero P., Mazumder A., Laubach J., Nadeem O., Sandberg A., Orre M., Torrang A., Bakker N.A., Richardson P.G.

مصطلحات موضوعية: health-related quality of life, melflufen, melphalan flufenamide, patient-reported outcome, relapsed/refractory multiple myeloma, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, Biomarkers, Tumor, Dexamethasone, Female, Human, Male, Melphalan, Middle Aged, Multiple Myeloma, Neoplasm Grading, Neoplasm Staging, Patient Reported Outcome Measure, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34671975; info:eu-repo/semantics/altIdentifier/wos/WOS:000709242300001; volume:196; issue:3; firstpage:639; lastpage:648; numberofpages:10; journal:BRITISH JOURNAL OF HAEMATOLOGY; http://hdl.handle.net/2318/1846953Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85117392564; https://doi.org/10.1111/bjh.17887Test

الإتاحة: https://doi.org/10.1111/bjh.17887Test
http://hdl.handle.net/2318/1846953Test

المؤلفون: Larocca, Alessandra, Leleu, Xavier, Touzeau, Cyrille, Bladé Creixenti, Juan, Paner, Agne, Mateos, M. V, Cavo, Michele, Maisel, Christopher, Alegre, Adrian, Oriol, Albert, Raptis, Anastasios, Rodriguez-Otero, Paula, Mazumder, Amitabha, Laubach, Jacob, Nadeem, Omar, Sandberg, Anna, Orre, Marie, TorrÃ¥ng, Anna, Bakker, Nicolaas A, Richardson, Paul G., Universitat Autònoma de Barcelona

مصطلحات موضوعية: Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Dexamethasone, Female, Humans, Male, Melphalan, Middle Aged, Multiple Myeloma, Neoplasm Grading, Neoplasm Staging, Patient Reported Outcome Measures, Treatment Outcome

وصف الملف: application/pdf

العلاقة: British Journal of Haematology; Vol. 196 Núm. 3 (february 2022), p. 639-648; https://ddd.uab.cat/record/270639Test; urn:10.1111/bjh.17887; urn:oai:ddd.uab.cat:270639; urn:scopus_id:85117392564; urn:articleid:13652141v196n3p639; urn:pmid:34671975; urn:pmc-uid:9135124; urn:pmcid:PMC9135124; urn:oai:pubmedcentral.nih.gov:9135124

الإتاحة: https://ddd.uab.cat/record/270639Test

المؤلفون: Richardson P. G., Oriol A., Larocca A., Blade J., Cavo M., Rodriguez-Otero P., Leleu X., Nadeem O., Hiemenz J. W., Hassoun H., Touzeau C., Alegre A., Paner A., Maisel C., Mazumder A., Raptis A., Moreb J. S., Anderson K. C., Laubach J. P., Thuresson S., Thuresson M., Byrne C., Harmenberg J., Bakker N. A., Mateos M. -V.

المساهمون: Richardson P.G., Oriol A., Larocca A., Blade J., Cavo M., Rodriguez-Otero P., Leleu X., Nadeem O., Hiemenz J.W., Hassoun H., Touzeau C., Alegre A., Paner A., Maisel C., Mazumder A., Raptis A., Moreb J.S., Anderson K.C., Laubach J.P., Thuresson S., Thuresson M., Byrne C., Harmenberg J., Bakker N.A., Mateos M.-V.

مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, Dexamethasone, Disease Progression, Drug Resistance, Neoplasm, Europe, Female, Human, Male, Melphalan, Middle Aged, Multiple Myeloma, Phenylalanine, Progression-Free Survival, Recurrence, Time Factor, United States

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33296242; info:eu-repo/semantics/altIdentifier/wos/WOS:000635371200008; volume:39; issue:7; firstpage:757; lastpage:767; numberofpages:11; journal:JOURNAL OF CLINICAL ONCOLOGY; https://hdl.handle.net/11585/865203Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85101703700

الإتاحة: https://doi.org/10.1200/JCO.20.02259Test
https://hdl.handle.net/11585/865203Test

المؤلفون: Mateos M. -V., Dimopoulos M. A., Cavo M., Suzuki K., Knop S., Doyen C., Lucio P., Nagy Z., Pour L., Grosicki S., Crepaldi A., Liberati A. M., Campbell P., Yoon S. -S., Iosava G., Fujisaki T., Garg M., Iida S., Blade J., Ukropec J., Pei H., Van Rampelbergh R., Kudva A., Qi M., San-Miguel J.

المساهمون: Mateos M.-V., Dimopoulos M.A., Cavo M., Suzuki K., Knop S., Doyen C., Lucio P., Nagy Z., Pour L., Grosicki S., Crepaldi A., Liberati A.M., Campbell P., Yoon S.-S., Iosava G., Fujisaki T., Garg M., Iida S., Blade J., Ukropec J., Pei H., Van Rampelbergh R., Kudva A., Qi M., San-Miguel J.

مصطلحات موضوعية: CD38, Clinical study, Efficacy, Frail, Monoclonal antibody, Aged, 80 and over, Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocol, Bortezomib, Female, Human, Male, Melphalan, Multiple Myeloma, Prednisone

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34344638; info:eu-repo/semantics/altIdentifier/wos/WOS:000713462500021; volume:21; issue:11; firstpage:785; lastpage:798; numberofpages:14; journal:CLINICAL LYMPHOMA MYELOMA & LEUKEMIA; https://hdl.handle.net/11585/864152Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85111556972; https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650Test(21)00210-X

الإتاحة: https://doi.org/10.1016/j.clml.2021.06.005Test
https://hdl.handle.net/11585/864152Test
https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650Test(21)00210-X

المؤلفون: Oliva S., Bruinink D. H., Rihova L., D'Agostino M., Pantani L., Capra A., van der Holt B., Troia R., Petrucci M. T., Villanova T., Vsianska P., Jugooa R., Brandt-Hagens C., Gilestro M., Offidani M., Ribolla R., Galli M., Hajek R., Gay F., Cavo M., Omede P., van der Velden V. H. J., Boccadoro M., Sonneveld P.

المساهمون: Oliva S., Bruinink D.H., Rihova L., D'Agostino M., Pantani L., Capra A., van der Holt B., Troia R., Petrucci M.T., Villanova T., Vsianska P., Jugooa R., Brandt-Hagens C., Gilestro M., Offidani M., Ribolla R., Galli M., Hajek R., Gay F., Cavo M., Omede P., van der Velden V.H.J., Boccadoro M., Sonneveld P.

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocol, Autograft, Bone Marrow Cell, Bortezomib, Dexamethasone, Disease-Free Survival, Female, Human, Lenalidomide, Male, Melphalan, Middle Aged, Neoplasm, Residual, Survival Rate, Flow Cytometry, Hematopoietic Stem Cell Transplantation, Multiple Myeloma

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34083504; info:eu-repo/semantics/altIdentifier/wos/WOS:000657729400001; volume:11; issue:6; firstpage:1; lastpage:9; numberofpages:9; journal:BLOOD CANCER JOURNAL; http://hdl.handle.net/11585/865103Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85107145070; https://www.nature.com/articles/s41408-021-00498-0Test

الإتاحة: https://doi.org/10.1038/s41408-021-00498-0Test
http://hdl.handle.net/11585/865103Test
https://www.nature.com/articles/s41408-021-00498-0Test

المؤلفون: Knop S., Mateos M. -V., Dimopoulos M. A., Suzuki K., Jakubowiak A., Doyen C., Lucio P., Nagy Z., Usenko G., Pour L., Cook M., Grosicki S., Crepaldi A., Liberati A. M., Campbell P., Shelekhova T., Yoon S. -S., Losava G., Fujisaki T., Garg M., Wang J., Wroblewski S., Kudva A., Gries K. S., Fastenau J., San-Miguel J., Cavo M.

المساهمون: Knop S., Mateos M.-V., Dimopoulos M.A., Suzuki K., Jakubowiak A., Doyen C., Lucio P., Nagy Z., Usenko G., Pour L., Cook M., Grosicki S., Crepaldi A., Liberati A.M., Campbell P., Shelekhova T., Yoon S.-S., Losava G., Fujisaki T., Garg M., Wang J., Wroblewski S., Kudva A., Gries K.S., Fastenau J., San-Miguel J., Cavo M.

مصطلحات موضوعية: Aged, Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocol, Bortezomib, Disease Progression, Drug Administration Schedule, Female, Human, Male, Melphalan, Middle Aged, Multiple Myeloma, Prednisone, Treatment Outcome, Patient Reported Outcome Measure, Quality of Life

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34078314; info:eu-repo/semantics/altIdentifier/wos/WOS:000660623100005; volume:21; issue:1; firstpage:659; lastpage:659; numberofpages:1; journal:BMC CANCER; http://hdl.handle.net/11585/867411Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85107143398; https://bmccancer.biomedcentral.com/articles/10.1186/s12885-021-08325-2Test

الإتاحة: https://doi.org/10.1186/s12885-021-08325-2Test
http://hdl.handle.net/11585/867411Test

المؤلفون: Mateos, Maria-Victoria, Cavo, Michele, Blade, Joan, Dimopoulos, Meletios A, Suzuki, Kenshi, Jakubowiak, Andrzej, Knop, Stefan, Doyen, Chantal, Lucio, Paulo, Nagy, Zsolt, Pour, Ludek, Cook, Mark, Grosicki, Sebastian, Crepaldi, Andre, Liberati, Anna Marina, Campbell, Philip, Shelekhova, Tatiana, Yoon, Sung-Soo, Iosava, Genadi, Fujisaki, Tomoaki, Garg, Mamta, Krevvata, Maria, Chen, Ying, Wang, Jianping, Kudva, Anupa, Ukropec, Jon, Wroblewski, Susan, Qi, Ming, Kobos, Rachel, San-Miguel, Jesus

المساهمون: UCL - (MGD) Service d'hématologie, UCL - SSS/IREC/MONT - Pôle Mont Godinne

المصدر: Lancet, Vol. 395, no. 10218, p. 132-141 (2020)

مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal, Asia, Bortezomib, Disease-Free Survival, Drug Administration Schedule, Drug Therapy, Combination, Europe, Female, Humans, Maintenance Chemotherapy, Male, Melphalan, Middle Aged, Multiple Myeloma, North America, Prednisone, South America, Survival Analysis, Treatment Outcome

العلاقة: boreal:226818; http://hdl.handle.net/2078.1/226818Test; info:pmid/31836199; urn:ISSN:0140-6736; urn:EISSN:1474-547X

الإتاحة: https://doi.org/10.1016/S0140-6736Test(19)32956-3
http://hdl.handle.net/2078.1/226818Test

المؤلفون: Mateos, M. -V., Dimopoulos, M. A., Cavo, M., Suzuki, K., Jakubowiak, A., Knop, S., Doyen, C., Lucio, P., Nagy, Z., Kaplan, P., Pour, L., Cook, M., Grosicki, S., Crepaldi, A., Liberati, A. M., Campbell, P., Shelekhova, T., Yoon, S. -S., Iosava, G., Fujisaki, T., Garg, M., Chiu, C., Wang, J., Carson, R., Crist, W., Deraedt, W., Nguyen, H., Qi, M., San-Miguel J., Foa R.

المساهمون: Mateos, M. -V., Dimopoulos, M. A., Cavo, M., Suzuki, K., Jakubowiak, A., Knop, S., Doyen, C., Lucio, P., Nagy, Z., Kaplan, P., Pour, L., Cook, M., Grosicki, S., Crepaldi, A., Liberati, A. M., Campbell, P., Shelekhova, T., Yoon, S. -S., Iosava, G., Fujisaki, T., Garg, M., Chiu, C., Wang, J., Carson, R., Crist, W., Deraedt, W., Nguyen, H., Qi, M., San-Miguel, J., Foa, R.

مصطلحات موضوعية: Adult, Aged, Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocol, Bortezomib, Disease-Free Survival, Female, Follow-Up Studie, Human, Infection, Intention to Treat Analysi, Kaplan-Meier Estimate, Male, Melphalan, Middle Aged, Multiple Myeloma, Prednisone, Survival Rate, Medicine (all)

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29231133; info:eu-repo/semantics/altIdentifier/wos/WOS:000424335200007; volume:378; issue:6; firstpage:518; lastpage:528; numberofpages:11; journal:NEW ENGLAND JOURNAL OF MEDICINE; http://hdl.handle.net/11573/1085850Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85042083059; http://www.nejm.org/medical-indexTest

الإتاحة: https://doi.org/10.1056/NEJMoa1714678Test
http://hdl.handle.net/11573/1085850Test
http://www.nejm.org/medical-indexTest

المؤلفون: Hani Hassoun, Jacob P. Laubach, Jan S. Moreb, Sara Thuresson, Paula Rodriguez-Otero, Marcus Thuresson, Michele Cavo, Albert Oriol, Maria-Victoria Mateos, Joan Bladé, John W. Hiemenz, Adrian Alegre, Amitabha Mazumder, Horizon (Op ) Investigators, Kenneth C. Anderson, Omar Nadeem, Johan Harmenberg, Nicolaas A Bakker, Xavier Leleu, Alessandra Larocca, Christopher Maisel, Paul G. Richardson, Agne Paner, Anastasios Raptis, Cyrille Touzeau, Catriona Byrne

المساهمون: Harvard Medical School [Boston] (HMS), Hospital Universitari Germans Trias I Pujol [Badalona], Università degli studi di Torino = University of Turin (UNITO), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona (UB), University of Bologna/Università di Bologna, Clínica Universidad de Navarra [Pamplona], Centre hospitalier universitaire de Poitiers (CHU Poitiers), University of Florida [Gainesville] (UF), Memorial Sloane Kettering Cancer Center [New York], Regulation of Bcl2 and p53 Networks in Multiple Myeloma and Mantle Cell Lymphoma (CRCINA-ÉQUIPE 10), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Université d'Angers (UA), Université de Nantes (UN), Site de Recherche Intégrée sur le Cancer [Nantes] (SIRIC), Centre hospitalier universitaire de Nantes (CHU Nantes), SIRIC ILIAD [Angers, Nantes], Hospital Universitario Quironsalud, Rush University Medical Center [Chicago], Baylor Scott & White Charles A. Sammons Cancer Center [Dallas, TX, USA], Oncology Institute of Hope and Innovation [Glendale, CA, USA] (OIHI), University of Pittsburgh School of Medicine, Pennsylvania Commonwealth System of Higher Education (PCSHE), Novant Health Forsyth Medical Center [Winston-Salem, NC, USA] (NHFMC), Oncopeptides AB [Stockholm, Sweden], Instituto de Investigación Biomédica de Salamanca [Salamanca, Spain] (IBSAL/CIC), HORIZON (OP-106) Investigators, Bernardo, Elizabeth, Università degli studi di Torino (UNITO), University of Bologna, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), Richardson P.G., Oriol A., Larocca A., Blade J., Cavo M., Rodriguez-Otero P., Leleu X., Nadeem O., Hiemenz J.W., Hassoun H., Touzeau C., Alegre A., Paner A., Maisel C., Mazumder A., Raptis A., Moreb J.S., Anderson K.C., Laubach J.P., Thuresson S., Thuresson M., Byrne C., Harmenberg J., Bakker N.A., Mateos M.-V.

المصدر: Journal of Clinical Oncology
Journal of Clinical Oncology, 2021, 39 (7), pp.757-767. ⟨10.1200/JCO.20⟩
Journal of Clinical Oncology, American Society of Clinical Oncology, 2021, 39 (7), pp.757-767. ⟨10.1200/JCO.20⟩
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

مصطلحات موضوعية: Adult, Male, Cancer Research, Time Factors, Time Factor, Phenylalanine, [SDV.CAN]Life Sciences [q-bio]/Cancer, Tumor cells, Drug resistance, Dexamethasone, 03 medical and health sciences, 0302 clinical medicine, [SDV.CAN] Life Sciences [q-bio]/Cancer, Recurrence, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Neoplasm, Progression-free survival, Melphalan, Aged, 030304 developmental biology, Aged, 80 and over, 0303 health sciences, Antineoplastic Combined Chemotherapy Protocol, business.industry, Refractory Multiple Myeloma, Middle Aged, medicine.disease, Progression-Free Survival, United States, 3. Good health, Europe, Clinical trial, Oncology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Disease Progression, Cancer research, Female, Multiple Myeloma, business, Human, Conjugate, medicine.drug

وصف الملف: application/pdf; STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79bb7c110aefa09f245d7dfe112c3ba4Test
https://doi.org/10.1200/jco.20.02259Test

المؤلفون: Michele Cavo, Vania Hungria, Bart Heeg, Andrea Garcia, Meletios A. Dimopoulos, Mariana Fernandez, Deborah M. Martínez-Baños, Maria-Victoria Mateos, Jianming He, Gerardo Machnicki, Annette Lam

المساهمون: Hungria V., Martinez-Banos D.M., Mateos M.-V., Dimopoulos M.A., Cavo M., Heeg B., Garcia A., Lam A., Machnicki G., He J., Fernandez M.

المصدر: Advances in Therapy

مصطلحات موضوعية: Male, Melphalan, 030213 general clinical medicine, medicine.medical_specialty, Population, Bortezomib, 03 medical and health sciences, 0302 clinical medicine, Multiple myeloma, Daratumumab, Propensity score matching, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Pharmacology (medical), Propensity Score, education, Aged, Retrospective Studies, Original Research, education.field_of_study, business.industry, Antibodies, Monoclonal, Standard of Care, General Medicine, Middle Aged, medicine.disease, Progression-Free Survival, Confidence interval, Hemato-Oncology Latin America, Latin America, ALYCONE, 030220 oncology & carcinogenesis, Cohort, Prednisone, Indirect treatment comparison, Female, business, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d30dae92d709ef6526889f33c6e8d32bTest
https://doi.org/10.1007/s12325-020-01521-9Test